<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[69]]></title><description><![CDATA[<p dir="auto">69<br />
Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients (PLRG8)<br />
This study is not yet open for participant recruitment.<br />
Verified on November 2011 by Polish Lymphoma Research Group</p>
<p dir="auto">First Received on November 14, 2011.   Last Updated on November 28, 2011   History of Changes<br />
Sponsor:  Polish Lymphoma Research Group<br />
Information provided by (Responsible Party):  Polish Lymphoma Research Group<br />
<a href="http://ClinicalTrials.gov" rel="nofollow ugc">ClinicalTrials.gov</a> Identifier:  NCT01481272</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/448398/69</link><generator>RSS for Node</generator><lastBuildDate>Sat, 20 Jun 2026 06:51:50 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/448398.rss" rel="self" type="application/rss+xml"/><pubDate>Tue, 29 Nov 2011 14:29:25 GMT</pubDate><ttl>60</ttl></channel></rss>